Aqua Bio Technology ASA (OSL: ABTEC)
Norway
· Delayed Price · Currency is NOK
3.280
+0.480 (17.14%)
At close: Jan 17, 2025
Aqua Bio Technology ASA Revenue
Aqua Bio Technology ASA had revenue of 61.05M NOK in the half year ending June 30, 2024, with 4,672.31% growth. This brings the company's revenue in the last twelve months to 13.82M, up 664.08% year-over-year. In the year 2022, Aqua Bio Technology ASA had annual revenue of 7.16M with 262.49% growth.
Revenue (ttm)
13.82M
Revenue Growth
+664.08%
P/S Ratio
5.00
Revenue / Employee
3.45M
Employees
4
Market Cap
363.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
Dec 31, 2020 | 812.63K | -482.56K | -37.26% |
Dec 31, 2019 | 1.30M | 78.16K | 6.42% |
Dec 31, 2018 | 1.22M | -8.66M | -87.68% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Photocure ASA | 526.25M |
Hofseth BioCare ASA | 248.08M |
Vistin Pharma ASA | 426.52M |
Nykode Therapeutics AS | 46.02M |
ArcticZymes Technologies ASA | 110.76M |
Omda AS | 419.59M |